Affordable Access

Publisher Website

Tirofiban

Authors
Identifiers
DOI: 10.1016/b978-008055232-3.62772-2
Keywords
  • Agent
Disciplines
  • Biology

Abstract

Tirofiban, an inhibitor of platelet aggregation, is a nonpeptide antagonist of the platelet glycoprotein IIb/IIIa receptor. Tirofiban, in combination with heparin, is indicated for the treatment of acute coronary syndrome. The effects of tirofiban are mediated through reversible antagonism of fibrinogen binding to the IIb/IIIa receptor …

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Tirofiban.

on Drugs of today (Barcelona, Spa... January 1999

[Update on tirofiban].

on La Presse Médicale Jan 20, 2001

Safety evaluation of tirofiban.

on Expert opinion on drug safety September 2010

Tirofiban and emergency coronary surgery.

on European journal of cardio-tho... October 2005
More articles like this..